SPL.AX
Price:
$0.11
Market Cap:
$45.99M
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, it develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase 2 clinical trials, DEP cabazitaxel that is in Phase 2 clinical trial, DEP gemcitabine that is in a Phase 1/2 clinical trials, and DEP irinotecan that is in Phase 2 clinical trials...[Read more]
Industry
Biotechnology
IPO Date
2000-09-27
Stock Exchange
ASX
Ticker
SPL.AX
According to Starpharma Holdings Limited’s latest financial reports and current stock price. The company's current Current Ratio is 4.94. This represents a change of 11.70% compared to the average of 4.42 of the last 4 quarters.
The mean historical Current Ratio of Starpharma Holdings Limited over the last ten years is 6.73. The current 4.94 Current Ratio has changed 7.24% with respect to the historical average. Over the past ten years (40 quarters), SPL.AX's Current Ratio was at its highest in in the March 2013 quarter at 16.00. The Current Ratio was at its lowest in in the March 2009 quarter at 0.
Average
6.73
Median
5.70
Minimum
3.26
Maximum
11.90
Discovering the peaks and valleys of Starpharma Holdings Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 126.56%
Maximum Annual Current Ratio = 11.90
Minimum Annual Increase = -45.08%
Minimum Annual Current Ratio = 3.26
Year | Current Ratio | Change |
---|---|---|
2024 | 4.94 | 51.77% |
2023 | 3.26 | -45.08% |
2022 | 5.93 | -12.61% |
2021 | 6.78 | 23.88% |
2020 | 5.48 | -26.39% |
2019 | 7.44 | -33.13% |
2018 | 11.13 | -6.48% |
2017 | 11.90 | 126.56% |
2016 | 5.25 | 1.32% |
2015 | 5.18 | -30.34% |
The current Current Ratio of Starpharma Holdings Limited (SPL.AX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.71
5-year avg
5.28
10-year avg
6.73
Starpharma Holdings Limited’s Current Ratio is greater than Mesoblast Limited (1.18), greater than Medical Developments International Limited (2.74), less than Pharmaxis Ltd (7.21), less than Nanosonics Limited (6.16), greater than Mayne Pharma Group Limited (1.47),
Company | Current Ratio | Market cap |
---|---|---|
1.18 | $3.22B | |
2.74 | $49.57M | |
7.21 | $20.23M | |
6.16 | $944.03M | |
1.47 | $370.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Starpharma Holdings Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Starpharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Starpharma Holdings Limited's Current Ratio?
How is the Current Ratio calculated for Starpharma Holdings Limited (SPL.AX)?
What is the highest Current Ratio for Starpharma Holdings Limited (SPL.AX)?
What is the 3-year average Current Ratio for Starpharma Holdings Limited (SPL.AX)?
What is the 5-year average Current Ratio for Starpharma Holdings Limited (SPL.AX)?
How does the current Current Ratio for Starpharma Holdings Limited (SPL.AX) compare to its historical average?